Scientists from the University of Utrecht in the Netherlands developed 47D11, a monoclonal antibody against the SARS-Cov-2 coronavirus.
Read for 1 min
New research gives hope to curb the spread of COVID-19. Scientist of the University of Utrecht, The Netherlands, led by Berend-Jan Bosch, found an experimental drug that could destroy the crown in the laboratory that helps the virus break and invade human cells.
The monoclonal antibody (mAB, monoclonal antibody) with the name 47D11, which was able to neutralize Covid-19 and SARS in laboratory cell cultures.
47D11 is not a vaccine, but an experimental drug, the researchers clarified. It could serve the common goal of containing the pandemic, the magazine said. Nature communication.
Monocloned antibodies are laboratory-made proteins that look like natural versions that the body develops to fight bacteria and viruses.